Journal article icon

Journal article

Assessment of local adverse reactions to subcutaneous immunoglobulin (SCIG) in clinical trials

Abstract:

In their recent paper on the North American pivotal trial of a new 20% immunoglobulin (Ig) for subcutaneous (SC) use, Suez et al. report an incidence of local adverse events (AE) of 0.015 events/infusion and compared this to rates reported in other studies of different products. Comparison of different products is inappropriate unless the products are studied contemporaneously within the same study using the same methodology, the same investigators, and the same patient populations. Judging t...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1007/s10875-017-0410-x

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDM; NDM Experimental Medicine
Role:
Author
Expand authors...
Publisher:
Springer Publisher's website
Journal:
Journal of Clinical Immunology Journal website
Volume:
37
Issue:
6
Pages:
517-518
Publication date:
2017-07-10
Acceptance date:
2017-06-06
DOI:
EISSN:
1573-2592
ISSN:
0271-9142
Pubs id:
pubs:899342
URN:
uri:502d7ebb-33b0-4883-a7f1-fe4112bd139e
UUID:
uuid:502d7ebb-33b0-4883-a7f1-fe4112bd139e
Local pid:
pubs:899342
Language:
English
Keywords:

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP